ID

15138

Descripción

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC; ODM derived from: https://clinicaltrials.gov/show/NCT02065362

Link

https://clinicaltrials.gov/show/NCT02065362

Palabras clave

Versiones (1)
  1. 18/5/16 18/5/16 -
Subido en

18 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

Inglés

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must meet the following eligibility inclusion criteria at the time of procurement:
Descripción

Time Procurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1709695
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
Descripción

Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278952
UMLS CUI [2,1]
C2931822
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C2347678
ebv positive tumor
Descripción

Malignant Neoplasms Epstein-Barr virus test positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1611703
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
the patient must meet the following eligibility criteria to be included for treatment:
Descripción

Inclusion criteria Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0087111
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
Descripción

Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278952
UMLS CUI [2,1]
C2931822
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C2347678
ebv positive tumor
Descripción

Malignant Neoplasms Epstein-Barr virus test positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1611703
patients with life expectancy greater than or equal to 6 weeks
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
bilirubin less than or equal to 3x upper limit of normal
Descripción

Bilirubin, total measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201913
ast less than or equal to 5x upper limit of normal
Descripción

Aspartate aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
hgb > 8.0g/dl (can be transfused)
Descripción

Hemoglobin | Transfusion (procedure)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019046
UMLS CUI [2]
C1879316
creatinine less than or equal to 2x upper limit of normal for age
Descripción

Creatinine measurement, serum | Upper Limit of Normal Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2,1]
C1519815
UMLS CUI [2,2]
C0001779
pulse oximetry of > 90% on room air
Descripción

Pulse Oximetry on room air

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034108
UMLS CUI [1,2]
C2709070
off investigational therapy for 4 weeks prior to study entry
Descripción

Off Investigational Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1518543
UMLS CUI [1,2]
C0949266
karnofsky or lansky score of greater than or equal to 50%
Descripción

Karnofsky Performance Status | Lansky Play-Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1522275
sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for 6 months after the study is concluded. the male partner should use a condom.
Descripción

Patients Sexually active | Contraceptive methods | Condoms, Male

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0241028
UMLS CUI [2]
C0700589
UMLS CUI [3]
C0009653
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
at time of procurement:
Descripción

Time Procurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1709695
•known hiv positivity
Descripción

HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
at time of treatment:
Descripción

Time Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0087111
pregnant or lactating
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
severe intercurrent infection
Descripción

Intercurrent infection Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0240021
UMLS CUI [1,2]
C0205082
Volver a la parte superior de la página

Similar models

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Time Procurement
Item
the patient must meet the following eligibility inclusion criteria at the time of procurement:
boolean
C0040223 (UMLS CUI [1,1])
C1709695 (UMLS CUI [1,2])
Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory
Item
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
boolean
C0278952 (UMLS CUI [1])
C2931822 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C2347678 (UMLS CUI [2,3])
Malignant Neoplasms Epstein-Barr virus test positive
Item
ebv positive tumor
boolean
C0006826 (UMLS CUI [1,1])
C1611703 (UMLS CUI [1,2])
Informed Consent
Item
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent
boolean
C0021430 (UMLS CUI [1])
Inclusion criteria Therapeutic procedure
Item
the patient must meet the following eligibility criteria to be included for treatment:
boolean
C1512693 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory
Item
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
boolean
C0278952 (UMLS CUI [1])
C2931822 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C2347678 (UMLS CUI [2,3])
Malignant Neoplasms Epstein-Barr virus test positive
Item
ebv positive tumor
boolean
C0006826 (UMLS CUI [1,1])
C1611703 (UMLS CUI [1,2])
Life Expectancy
Item
patients with life expectancy greater than or equal to 6 weeks
boolean
C0023671 (UMLS CUI [1])
Bilirubin, total measurement
Item
bilirubin less than or equal to 3x upper limit of normal
boolean
C0201913 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
ast less than or equal to 5x upper limit of normal
boolean
C0201899 (UMLS CUI [1])
Hemoglobin | Transfusion (procedure)
Item
hgb > 8.0g/dl (can be transfused)
boolean
C0019046 (UMLS CUI [1])
C1879316 (UMLS CUI [2])
Creatinine measurement, serum | Upper Limit of Normal Age
Item
creatinine less than or equal to 2x upper limit of normal for age
boolean
C0201976 (UMLS CUI [1])
C1519815 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
Pulse Oximetry on room air
Item
pulse oximetry of > 90% on room air
boolean
C0034108 (UMLS CUI [1,1])
C2709070 (UMLS CUI [1,2])
Off Investigational Therapy
Item
off investigational therapy for 4 weeks prior to study entry
boolean
C1518543 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Karnofsky Performance Status | Lansky Play-Performance Status
Item
karnofsky or lansky score of greater than or equal to 50%
boolean
C0206065 (UMLS CUI [1])
C1522275 (UMLS CUI [2])
Patients Sexually active | Contraceptive methods | Condoms, Male
Item
sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for 6 months after the study is concluded. the male partner should use a condom.
boolean
C0030705 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2])
C0009653 (UMLS CUI [3])
Informed Consent
Item
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Time Procurement
Item
at time of procurement:
boolean
C0040223 (UMLS CUI [1,1])
C1709695 (UMLS CUI [1,2])
HIV Seropositivity
Item
•known hiv positivity
boolean
C0019699 (UMLS CUI [1])
Time Therapeutic procedure
Item
at time of treatment:
boolean
C0040223 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Intercurrent infection Severe
Item
severe intercurrent infection
boolean
C0240021 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial